AI-led precision medicine and mechanistic patient stratification for complex chronic diseases

Complex chronic diseases present the most difficult and expensive challenges in drug development and healthcare. PrecisionLife has uniquely identified causal biology in over 50 indications to map targets, trials, and treatments to patients based on the molecular mechanisms of their disease and drug response. See how this approach is increasing the probability of success for new diagnostics and treatments and find out about our de-risked precision medicine programs and the rapid progress of our biomarker-led clinical trials.